We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Polymorphids an mRNA Expression in Obese Genes

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01708083
First Posted: October 16, 2012
Last Update Posted: August 22, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Anders Thorell, Karolinska Institutet
  Purpose

Fat tissue from omenta, thigh and abdomen taken under anesthesia on subjects undergoing laparoscopic surgery, cholecystectomy, reflux surgery or gastric by-pass (GBP).

Are there any difference in polymorphids and/or mRNA expression in genes significant for developing obesity, between normal weight and obese individuals, with or without diabetes typ 2 .

Are there any difference in polymorphids and/or mRNA expression in different types of fat tissue


Condition
Polymorphism mRNA Expression

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Polymorphids and mRNA Expression in Genes, Significant for Developing Obesity and Typ II Diabetes in Different Types/Localisations of Fat Tissue

Resource links provided by NLM:


Further study details as provided by Anders Thorell, Karolinska Institutet:

Primary Outcome Measures:
  • Differences in polymorphids and/or mRNA expression in genes, significant for developing obesity and type 2 diabetes, between patients with normal weight and obesity [ Time Frame: approximatly 30 minutes after start of operation ]
    fat biopsy taken from abdomen, omenta and thigh at surgery

  • Difference in polymorphids and/or mRNA expression in different types of fat tissue in patients with normal weight or obesity with or without diabetes type 2 [ Time Frame: approximatly 30 minutes after start of operation ]
    fat biopsy; abdomen, omenta and thigh taken at surgery


Biospecimen Retention:   Samples With DNA
biopsys; Fat from oment, thigh and abdomen

Enrollment: 50
Study Start Date: January 2010
Study Completion Date: February 2013
Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
Type 2 Diabetes and BMI>35
Patients with type 2 diabetes and body mass index 35 or more.
BMI>35
Patients undergoing surgery, gastric bypass or cholecystectomy, without diabetes type 2 and body mass index 35 or more
BMI 18-27
Patients undergoing surgery, cholecystectomy or reflux, without type 2 diabetes and body mass index between 18-27

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Tree groups; group I: diabetes type II with BMI>35 Group II: no diabetes BMI>35 Group III: no diabetes BMI 18-27
Criteria

Inclusion Criteria:

  • age 18 years or older
  • laparoscopic surgery (Gastric by-pass, cholecystectomy, antireflux surgery)
  • Normal weight without type 2 diabetes BMI 18-25
  • Obese without type 2 diabetes BMI>35
  • Obese with type 2 diabetes BMI>35

Exclusion Criteria:

  • under 18 years
  • open surgery
  • pregnancy
  • BMI >27-<35
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01708083


Locations
Sweden
Ersta hospital
Stockholm, Stockholm County Council, Sweden, 116 91
Karolinska Institutet, CMM
Stockholm, Sweden, 171 76
Sponsors and Collaborators
Karolinska Institutet
Investigators
Principal Investigator: Anders Thorell, Ass. prof. Karolinska Institutet
  More Information

Responsible Party: Anders Thorell, Associated professor, MD, Karolinska Institutet
ClinicalTrials.gov Identifier: NCT01708083     History of Changes
Other Study ID Numbers: 2009/1629-31/3
First Submitted: October 9, 2012
First Posted: October 16, 2012
Last Update Posted: August 22, 2013
Last Verified: August 2013